As the market slides, all stages of investing have been taking a hit, from the earliest rounds to the last. In Q1, U.S., startups raised $14.8 billion an 18.6 percent decrease from the $18.2 million invested in the year ago quarter. There were 1,035 deals in Q1; not only was that down over 17 percent year-to-year, its the lowest number of investments made since the first quarter of 2012.
And, at the current rate, 2016’s figures might actually wind up being lower than 2011.
Even when there's a down market, though, there are still going to be plenty of companies raising money. In the Series A round, for example, which has seen 1,500 deals in each of past two years, it going to dip this year, but is still on pace to see 1,150 deals done this year.
Pitchbook has put together the list of the top 10 Series A investors in venture capital, based on the number of deals, since the start of 2014, out of the 2,166 investors who have made an investment in that stage.
The top investor has been Sequoia Capital, with a total of 76 Series A investments in the past two and half years. Some of those companies have included Guardant Health, Clever, DoorDash, Metanautix, ZoomCar, and PlanGrid.
Coming up right behind Sequoia is New Enterprise Associates, which has made 75 such investments since the start of 2014. Investments have included Collective Health, Jet, Branch Metrics, Hello Alfred, Stride Health and LearnUp.
In third was Accel, which has invested in 63 Series A investments, including in PandoDaily, Sprig, Jet, Weaveworks and CleverTap.
SV Angel was next on the list with 54 investments. It's portfolio companies include Oyster, Fundera, Secret, Opendoor, Cargomatic, MileIQ and CrunchBase.
Rounding out the top five is GV, with 51 Series A investments in 30 months. They included Medium, Collective Health, Secret, Robinhood, Checkr, Cockroach Labs, MindMeld, and Boxbee.
The rest of the top 10 largest investors were Andreessen Horowitz, with 50; First Round Capital, with 46; and then Index Ventures, Greycroft Partners and Data Collective, all with 42 Series A investments.
Since the start of 2014, all of those investors have collectively, invested $26.15 billion into 3,478 Series A round. Nearly half went to the IT industry, while 18 percent went to B2C companies, and 16 percent went to healthcare companies.
(Image source: measurablesolutions.wordpress.com)
This will allow DrFirst to accelerate its growth in the specialty medication space
Read more...
Steven Loeb
The company initially raised $3 million in seed funding when it launched in October
Read more...
Steven Loeb
This is the company's first fundraising since 2019 and brings its total capital to $103M
Read more...
Steven Loeb
Angel group/VC
Joined Vator on
Andreessen Horowitz is a $2.5 billion venture capital firm that was launched on July 6, 2009. Marc Andreessen, Ben Horowitz, John O’Farrell, Scott Weiss, Jeff Jordan, and Peter Levine are the general partners of the firm.
Angel group/VC
Joined Vator on
Sequoia Capital is a venture capital firm founded by Don Valentine in 1972. The Wall Street Journal has called Sequoia Capital “one of the highest-caliber venture firms” and noted that it is “one of Silicon Valley’s most influential venture-capital firms”. It invests between $100,000 and $1 million in seed stage, between $1 million and $10 million in early stage, and between $10 million and $100 million in growth stage.
Angel group/VC
Joined Vator on
We move at startup speed. We’re transforming a portfolio of individual companies into a connected community of entrepreneurs who inspire, support and educate each other
Angel group/VC
Joined Vator on
Many venture firms would be best described as a collection of free agents who pursue their own deals and share offices and overhead with their partners. They are more mercenary than missionary and will tell you to focus more on the individual partners and less on the partnership. We hope to have the opportunity to show you how we are different.
We are true partners who have built our own firm together, brick by brick; the same way you are building your company. When we commit to supporting your company, each and every partner in our firm commits to contributing his or her network, creativity and resources towards achieving your success. We are big believers in the power of teams.
We believe you will want an investor with whom you can build a close, supportive relationship over a number of years, yet who will be bold enough to challenge your thinking and your expectations. If Index looks like a good fit, we encourage you to learn about us through the stories and news articles on this website. We invite you to read about the companies we have invested in, and to speak to the entrepreneurs we have partnered with. Their experience is our best reference.
Startup/Business
Joined Vator on
Guardant Health is focused on developing breakthrough diagnostic technologies that can transform cancer from a silent killer into a manageable disease. The company was founded in 2012 by a team of serial entrepreneurs with expertise in next-generation sequencing, single-cell genomics and cancer diagnostics. The team is committed to positively and significantly impacting patient health through technology that addresses long-standing unmet needs in oncology.
